Trial Profile
Clinical Trial on Efficacy and Tolerability of Two Different Single Doses of Avanafil in Russia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Avanafil (Primary)
- Indications Erectile dysfunction
- Focus Registrational; Therapeutic Use
- Acronyms CEDAR
- Sponsors Sanofi
- 16 Mar 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 10 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 03 Aug 2015 Status changed from not yet recruiting to recruiting ClinicalTrials.gov